-
1
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
3
-
-
0032188859
-
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study
-
(1998)
Eur Heart J
, vol.19
, pp. 1552-1563
-
-
Vantrimpont, P.1
Rouleau, J.L.2
Ciampi, A.3
Harel, F.4
De Champlain, J.5
Bichet, D.6
Moye, L.A.7
Pfeffer, M.8
-
5
-
-
0031871031
-
Neurohormonal activation in the treatment of congestive heart failure: Basis for new treatments?
-
(1998)
Cardiology
, vol.90
, pp. 1-7
-
-
Pool, P.E.1
-
6
-
-
0023266532
-
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
-
(1987)
N Engl J Med
, vol.316
, pp. 1429-1435
-
-
-
7
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
-
8
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
9
-
-
0033517302
-
The effect of spironolactone on mortality and morbidity in patients with severe heart failure
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
14
-
-
0029619616
-
Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure
-
(1995)
J Pharmacol Exp Ther
, vol.275
, pp. 745-752
-
-
Trippodo, N.C.1
Robl, J.A.2
Asaad, M.M.3
Bird, J.E.4
Panchal, B.C.5
Schaeffer, T.R.6
Fox, M.7
Giancarli, M.R.8
Cheung, H.S.9
-
17
-
-
0031693940
-
Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
-
(1998)
J Cardiovasc Pharmacol
, vol.32
, pp. 902-912
-
-
Thomas, C.V.1
McDaniel, G.M.2
Holzgrefe, H.H.3
Mukherjee, R.4
Hird, R.B.5
Walker, J.D.6
Hebbar, L.7
Powell, J.R.8
Spinale, F.G.9
-
20
-
-
0026667250
-
Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial)
-
(1992)
Am J Cardiol
, vol.70
, pp. 479-487
-
-
Ljungman, S.1
Kjekshus, J.2
Swedberg, K.3
-
21
-
-
0031955506
-
Effects of omapatrilat in low, normal, and high renin experimental hypertension
-
(1998)
Am J Hypertens
, vol.11
, pp. 363-372
-
-
Trippodo, N.C.1
Robl, J.A.2
Asaad, M.M.3
Fox, M.4
Panchal, B.C.5
Schaeffer, T.R.6
-
22
-
-
0033862042
-
The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 479-486
-
-
McClean, D.R.1
Ikram, H.2
Garlick, A.3
Richards, A.M.4
Nicholls, M.G.5
Crozier, I.G.6
-
24
-
-
0001022542
-
Vasopeptidase inhibitor or angiotensin converting enzyme inhibitor in heart failure? Results of the IMPRESS trial
-
(1999)
Circulation
, vol.100
-
-
Rouleau, J.L.1
Pfeffer, M.A.2
Stewart, D.J.3
Kenut, E.K.4
Porter, C.B.5
Parker, J.O.6
Smith, L.K.7
Proulx, G.8
Qian, C.9
Block, A.J.10
-
31
-
-
0032805710
-
Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure
-
(1999)
Circulation
, vol.100
, pp. 2443-2448
-
-
Chen, H.H.1
Schirger, J.A.2
Chau, W.L.3
Jougasaki, M.4
Lisy, O.5
Redfield, M.M.6
Barclay, P.T.7
Burnett J.C., Jr.8
-
33
-
-
0030842484
-
Intrarenal determinants of sodium retention in mild heart failure: Effects of angiotensin-converting enzyme inhibition
-
(1997)
Hypertension
, vol.30
, pp. 168-176
-
-
Volpe, M.1
Magri, P.2
Rao, M.A.3
Cangianiello, S.4
DeNicola, L.5
Mele, A.F.6
Memoli, B.7
Enea, I.8
Rubattu, S.9
Gigante, B.10
Trimarco, B.11
Epstein, M.12
Condorelli, M.13
-
34
-
-
0029656247
-
Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neuro-hormonal activation in patients with congestive heart failure
-
(1996)
Cardiology
, vol.87
, pp. 46-53
-
-
Kimmelstiel, C.D.1
Perrone, R.2
Kilcoyne, L.3
Souhrada, J.4
Udelson, J.5
Smith, J.6
De Bold, A.7
Griffith, J.8
Konstam, M.A.9
-
35
-
-
0033049453
-
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers
-
(1999)
J Hypertens
, vol.17
, pp. 427-437
-
-
Rousso, P.1
Buclin, T.2
Nussberger, J.3
Decosterd, L.A.4
La Roche, S.D.5
Brunner-Ferber, F.6
Brunner, H.R.7
Biollaz, J.8
|